These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6542604)

  • 21. Leukemia with megakaryocytic differentiation following essential thrombocythemia and myelofibrosis. Case report and review of the literature.
    Patiño-Sarcinelli F; Knecht H; Pechet L; Pihan G; Savas L; Snyder LM
    Acta Haematol; 1996; 95(2):122-8. PubMed ID: 8638441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased phospho-mTOR expression in megakaryocytic cells derived from CD34+ progenitors of essential thrombocythaemia and myelofibrosis patients.
    Vicari L; Martinetti D; Buccheri S; Colarossi C; Aiello E; Stagno F; Villari L; Cavalli M; Di Raimondo F; Gulisano M; De Maria R; Vigneri P
    Br J Haematol; 2012 Oct; 159(2):237-40. PubMed ID: 22924455
    [No Abstract]   [Full Text] [Related]  

  • 23. [Acute megakaryoblastic leukemia accompanied by marked plasmacytosis in the terminal stage: report of a case].
    Honda K; Kamiya T; Ookawa H; Kiryu Y; Yamamoto Y; Yokomizo M; Kizaki M; Toyama K; Harigaya K; Enomoto Y
    Rinsho Ketsueki; 1986 May; 27(5):747-51. PubMed ID: 3747168
    [No Abstract]   [Full Text] [Related]  

  • 24. [Myelofibrosis with dermal myeloid metaplasia. Presentation of a case].
    Rodríguez Silva H; Nasiff Hadad A
    Sangre (Barc); 1984; 29(1):87-90. PubMed ID: 6585991
    [No Abstract]   [Full Text] [Related]  

  • 25. [Malignant proliferations of the megakaryocyte and acute megakaryoblastic leukemia].
    Duhamel G
    Ann Med Interne (Paris); 1981; 132(1):1-2. PubMed ID: 7194616
    [No Abstract]   [Full Text] [Related]  

  • 26. Extramedullary megakaryoblastic tumors following an indolent phase of myelofibrosis.
    Chubachi A; Wakui H; Miura I; Saitoh M; Nishinari T; Nishimura S; Miura AB
    Leuk Lymphoma; 1995 Apr; 17(3-4):351-4. PubMed ID: 8580808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of megakaryoblastic leukemia showing features like primary myelofibrosis].
    Takizawa S; Sanada M; Tsukada T; Koike T; Shibata A
    Rinsho Ketsueki; 1984 Dec; 25(12):1967-72. PubMed ID: 6543457
    [No Abstract]   [Full Text] [Related]  

  • 28. Acquired von Willebrand's disease in myelofibrosis and essential thrombocythemia.
    Goyal J; Reddy VV; Marques MB
    Haemophilia; 2013 Jul; 19(4):e256-7. PubMed ID: 23590694
    [No Abstract]   [Full Text] [Related]  

  • 29. [Splenic megakaryocytic metaplasia in osteomyelosclerosis--case report].
    Polko M; Polanowicz U; Górka A
    Wiad Lek; 1993 Jun; 46(11-12):452-5. PubMed ID: 8116295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the study of megakaryocytic leukemia.
    Shibata A
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1743-52. PubMed ID: 3915407
    [No Abstract]   [Full Text] [Related]  

  • 31. Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia.
    Hill G; McClean D; Fraser R; Hart D; Crozier I; Snowden J; Gibbons S
    Aust N Z J Med; 1996 Dec; 26(6):852-3. PubMed ID: 9028525
    [No Abstract]   [Full Text] [Related]  

  • 32. Micromegakaryocytic transformation of myelofibrosis with myeloid metaplasia.
    Rosangela I; Pecci A; Formisano R
    Haematologica; 2000 Jan; 85(1):98-9. PubMed ID: 10629600
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute megakaryoblastic transformation of essential thrombocythemia.
    Vianelli N; Baravelli S; Gugliotta L
    Haematologica; 1996; 81(3):288-9. PubMed ID: 8767538
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary myelofibrosis terminating in megakaryoblastic crisis.
    Kurashima K; Kawamura Y; Ohka T; Hayashi M; Matsuda T
    Jpn J Med; 1990; 29(2):226-9. PubMed ID: 2232372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute myelogenous leukemia with megakaryocytic myelosis.
    Habib A; Lee H; Chan M
    Am J Clin Pathol; 1980 Nov; 74(5):705-9. PubMed ID: 6934691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transition of essential thrombocythemia to megakaryoblastic leukemia after long-term therapy with sequential busulfan, pipobroman and hydroxyurea.
    Sironi M; Bertola G; Lodato A; Spinelli M; Sciariada L
    Acta Haematol; 2003; 109(3):161-2. PubMed ID: 12714827
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute megakaryo-monocytic leukemia with acute myelofibrosis.
    Murayama T; Imoto S; Matsuoka H; Iwata N; Taniguchi T; Ito M; Chihara K; Matsui T; Hayashi Y; Obayashi C
    Am J Hematol; 1996 Oct; 53(2):147-8. PubMed ID: 8892748
    [No Abstract]   [Full Text] [Related]  

  • 39. Megakaryocytic leukaemia as a phase of myeloproliferative disorders.
    Egner JR; Aabo D; Dimitrov NV
    Scand J Haematol; 1982 Feb; 28(2):186-91. PubMed ID: 7201156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ultrastructural study of platelets in acute myelofibrosis].
    Rozman C; Brugués R
    Sangre (Barc); 1982; 27(6):1030-9. PubMed ID: 6764035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.